Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 2,108 shares (to pay taxes)
  2. 4 Open-market buy Director bought 1,867,912 shares at $3.25 ($6,070,714)
  3. 4 Shares withheld for taxes Chief Accounting Officer gave up 798 shares (to pay taxes)
  4. 4 Insider Changes in Ownership
  5. 4 Shares withheld for taxes Chief Accounting Officer gave up 797 shares (to pay taxes)
  6. 4 Insider Changes in Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes Interim Principal Exec Officer gave up 339 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Accounting Officer gave up 866 shares (to pay taxes)
  10. 4 Grant or award Director acquired 16,917 shares (grant or award)
  11. 4 Grant or award Director acquired 16,917 shares (grant or award)
  12. 4 Grant or award Director acquired 16,917 shares (grant or award)
  13. 4 Grant or award Director acquired 16,917 shares (grant or award)
  14. 4 Grant or award Director acquired 16,917 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy 10% owner bought 7,717,661 shares at $2.87 ($22,149,687)
  17. 4/A Grant or award Interim Principal Exec Officer acquired 15,734 shares (grant or award)
  18. 4/A Grant or award Chief Accounting Officer acquired 8,741 shares (grant or award)
  19. 4 Shares withheld for taxes Interim Principal Exec Officer gave up 1,549 shares (to pay taxes)
  20. 4 Open-market sale Chief Accounting Officer sold 2,954 shares at $14.78 ($43,660)

Page 7 of 39 · 776 filings